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http://dx.doi.org/10.1016/j.jfma.201Humannonplagueyersiniosisoccursmorecommonly in temperate regions than intropicalor subtrop-
ical regions. In Taiwan,which is located in a subtropical region of Southeast Asia, only environmental
isolates and human infection of Yersinia enterocoliticawere reported, but a human case of Y. pseu-
dotuberculosis infection had not been identified. We report the first person with Y. pseudotubercu-
losis serotype O1 septicemia who presented with acute appendicitis-like syndrome and who was
probably contracted the infection via ingestion of raw foods in a barbecue restaurant in Japan.
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developed in the following 3 days. His friends also experi-Human nonplague yersiniosis, mainly caused by the infec-
tion of Yersinia enterocolitica and Y. pseudotuberculosis,
occurs more commonly in temperate regions than in trop-
ical or subtropical regions.1 Outbreaks of Y. pseudotuber-
culosis have been reported in Finland,2,3 France,4 and
Japan.5,6 In Taiwan, which is located in a subtropical region
of Southeast Asia, only a few isolates of Y. enterocolitica
from swine7e9 and human10,11 have reported. Neither
human infection nor nonhuman isolate of Y. pseudotuber-
culosis had been identified in Taiwan. Herein, we report the
first human case of Y. pseudotuberculosis septicemia in
Taiwan, which was probably imported from Japan.
Case report
A Taiwanese businessman who was 33 years of age and who
had resided in Osaka, Japan, for more than 6 months, pre-
sented to our emergency department with chief complaints
of intermittent fever, abdominal pain, diarrhea, and
progressive jaundice for 5 days at the end of May 2010. He
recalled that he had eaten at a barbecue restaurant with
friends 2 days before the illness occurred. In addition to
barbecue, he also ate raw cattle liver (liver sashimi), fish
sashimi, raw Tako (octopus), and semi-boiled pig’s ear.
Abdominal pain and mild diarrhea occurred in the firstFigure 1 (A) Abdominal computed tomography disclosed a bow
inflammatory change over the local mesentery (white arrowhead
microorganism showed Gram-negative bacilli with the characterist
merase chain reaction products of virF, ypmA, and ypmB genes, in
ypmA (YPMa), but an absence of ypmB (YPMb). BZ blank; MZma2 days, and vomiting, fever, and progressive jaundice
enced mild gastrointestinal upset, but neither of them had
abdominal pain, diarrhea, or fever. He sought medical
help in Japan, but the symptoms persisted despite the
prescribed medication. He came back to Taiwan and visited
our emergency department immediately. Clinically, he had
a high fever with a body temperature of 40C, icteric sclera,
and tenderness over the right lower abdomen. The blood
examination revealed a white cell count of 12,760/mm3,
a hemoglobin level of 13.5 g/dl, and a platelet count of
193,000/mm3. The biochemical tests showed the following:
blood urea nitrogen level of 24.3 mg/dL, serum creatinine
level of 1.7 mg/dL, alanine transaminase level of 62 U/L,
aspartate transaminase level of 52 U/L, total bilirubin level
of 6.85 mg/dL, alkaline phosphatase level of 820 U/L,
C-reactive protein level of 148 mg/L, and glucose level of
121 mg/dL. Electrolytes, amylase, and lipase were within
normal limits. The findings of chest X-ray, abdominal plain
view, and abdominal ultrasonography were unremarkable.
The stool examination was positive for occult blood test,
but no inflammatory cells, pus, parasites, or ova were
found. The abdominal computed tomography revealed
segmental wall thickening over the terminal ileum with
regional lymphadenopathy; terminal ileitis was considered
by the radiologist (Fig. 1A). However, shock developed
a few hours later. The patient was admitted under the
tentative diagnosis of infectious diarrhea and septic shockel wall thickening over the terminal ileum (white arrow) and
s), indicating terminal ileitis; (B) Gram stain of the isolated
ic of bipolar stain (black arrows); (C) electrophoresis of poly-
dicating that the isolated strain has presence of virF (pYV) and
rker.
658 C.-H. Lai et al.and empiric antibiotic with moxifloxacin was administered.
The results of serum anti-hepatitis A virus (HAV) IgM, HBs
Ag, anti-HBc IgM, anti-Hepatitis C virus, amebiasis anti-
body, anti-HIV, and venereal disease research laboratory
(VDRL) tests were all negative. The blood culture yielded
a growth of Gram-negative bacilli with the characteristic
of bipolar-stain 2 days later (Fig. 1B). The bacterium was
identified as Y. pseudotuberculosis later by API 20E (bio-
Me’rieux, Marcy l’Etoile, France) and VITEK 2 Automated
Microbiology System GN (Ref. 21341/AST-N081) (bio-
Me´rieux, Marcy l’Etoile, France), and BD Phoenix Auto-
mated Microbiology System (Becton Dickinson, Sparks, MD,
USA) with panel NMIC/ID-4 and NMIC/ID-32. The antibiotic
was changed to a combination of ciprofloxacin and genta-
micin according to the results of antimicrobial suscepti-
bility tests (Table 1).12 No pathogenic bacterium was
isolated from stool culture. The fever, abdominal pain,
diarrhea, and hyperbilirubinemia resolved and the patient
recovered uneventfully after a 10-day course of intrave-
nous antibiotic therapy.
Molecular identification, serotyping, and virulence
genes detection
The 16S ribosomal DNA of the isolate was obtained by poly-
merase chain reaction and its sequence was > 99% identicalTable 1 Results of antimicrobial susceptibility tests of the isol
Antimicrobial agents BD Phoen
MIC (ug/ml)
Amikacin 8
Amoxicillin/clavulanate 4/2
Ampicillin 4
Ampicillin/sulbactam 4/2
Aztreonam > 16
Cefazolin 4
Cefepime 2
Cefotaxime 4
Cefoxitin 4
Ceftazidime 0.5
Ceftriaxone 8
Cefuroxime 4
Chloramphenicol 4
Ciprofloxacin 0.5
Colistin > 2
Ertapenem NA
Gentamicin 2
Imipenem 1
Levofloxacin 1
Meropenem 1
Moxifloxacin 1
Nitrofurantoin 32
Piperacillin 4
Piperacillin/tazobactam 4/4
Tetracycline 2
Tigecycline NA
Trimethoprim/sulfamethoxazole 0.5/9.5
MICZminimal inhibitory concentration; NAZ not available; NDZ no
Institute (CLSI) Antimicrobial Susceptibility Testing12; SZ susceptibleto the 16S rDNA of the Y. pseudotuberculosis (ATCC 29833,
GenBank accession no. AF366375) using NCBI BLAST.
Y. pseudotuberculosis serotype O1 was identified using
the commercial available antisera (Denka Seiken, Tokyo,
Japan). Detection of virulence genes was performed as
described previously.13 The isolated strain showed presence
of pYV (70-kb virulence plasmid) for virF, and one variant
of Y. pseudotuberculosisederived mitogen (YPM), YPMa, for
ypmA, but the absence of YPMb, YPMc (Fig. 1C), and high
pathogenicity island (HPI). Combined with the results of
serotype O1 and associated genetic detection, the isolated
Y. pseudotuberculosis belonged to a genetic group 3 (YPMaþ,
HPI-), indicating a Far East systemic pathogenicity type.13
Discussion
Y. pseudotuberculosis, secondary to Y. enterocolitica, is
one of the two most common yersinia species causing
human nonplague yersiniosis. It can be recovered from the
natural environment or animal reservoirs, including
rodents, rabbits, domestic animals (particularly pigs), and
birds.1 Human infection occurs via ingestion of food or
water contaminated with the organism. Common manifes-
tations of Y. pseudotuberculosis infection include gastro-
enterocolitis, acute mesenteric adenitis, and terminal ileitis,
which is also known as acute appendicitis-like syndrome.1ated Y. pseudotuberculosis serotype O1.
ix VITEK 2
Susceptibility MIC (ug/ml) Susceptibility
S 2 S
S NA NA
S 2 S
S 2 S
R NA NA
S 4 S
S 1 S
S NA NA
S NA NA
S 1 S
S 1 S
S NA NA
S NA NA
S 0.25 S
ND NA NA
NA 0.5 S
S 1 S
S NA NA
S 0.12 S
S 0.25 S
ND NA NA
S NA NA
S 4 S
S 4 S
S 2 S
NA 0.5 ND
S 20 S
interpretative data based on Clinical and Laboratory Standards
; IZ intermediate; RZ resistant.
Yersinia pseidotuberculosis in Taiwan 659Several outbreaks of Y. pseudotuberculosis have been
reported.2e6 In Finland, the contaminated source was
traced to iceberg lettuce2 and raw carrots.3 An increased
Y. pseudotuberculosis in human was supposed to be related
to increased prevalence of the pathogen in rodent reser-
voirs in France.4 In the two reports from Japan, contami-
nated vegetable juice might be responsible for
a community outbreak,5 and two groups of people acquired
infection after eating meat products, vegetables, and rice
at the same barbecue restaurant sequentially.6 The incu-
bation period of intestinal yersiniosis is about 3 to 7 days1
and the patient recalled the illness developed few days
after the meal at the barbecue; we supposed that the
patient was infected via ingestion of contaminated raw or
incompletely broiled foods at the barbecue restaurant in
Osaka, Japan. However, it was impossible to trace the
exact foods he had eaten at that time.
Our report is different from previous reports indicating
that septicemic cases of Y. pseudotuberculosis commonly
occur in patients with underlying diseases of diabetes
mellitus, liver cirrhosis, malignancy, thalassemia, iron-
overload disorders, and immunocompromised status such
as postorgan transplantation and HIV infection,14e16 since
none of these was found in this patient. This might suggest
an ingestion of large bacterial load, an infection with more
virulent strain, or a failure to identify possible predisposing
diseases in this case.
Except for aztreonam and colistin, the isolated
Y. pseudotuberculosis serotype O1 are susceptible to most
antimicrobial agents tested, including the newer ones of
ertapenem, levofloxacin, moxifloxacin, and tigecycline
(Table 1). In vitro, Y. pseudotuberculosis was reported to
be susceptible to ampicillin, tetracycline, chloramphen-
icol, cephalosporins, and aminoglycosides. Among these,
ampicillin is the recommended antibiotic to treat severe
infection. However, the mortality rate of septicemia is as
high as 75% despite antibiotic therapy.16 Because of this
high mortality rate and initial presentation of septic shock
in this patient, a combination of ciprofloxacin and genta-
micin rather than ampicillin was administered following the
moxifloxacin. Fortunately, the patient responded well and
survived. The excellent outcome of this case might due to
no other underlying diseases and receiving newer antibiotic
therapy. In conclusion, this report not only describes the
first human Y. pseudotuberculosis infection in Taiwan, but
it also suggests that this organism may be transported
between countries and from temperate regions to tropical
or subtropical regions via human infection.Acknowledgments
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